Effect of Liraglutide vs CPAP on Cardiometabolic Outcomes in Obstructive Sleep Apnea
Status:
Recruiting
Trial end date:
2022-03-31
Target enrollment:
Participant gender:
Summary
This is an explorative, proof-of-concept study exploring the potential therapeutic role of a
Liraglutide-based weight loss regimen versus standard CPAP or the combination of both on
metabolic parameters, blood pressure, endothelial function, coronary artery calcification,
vascular inflammation and apnea/hypopnea index in non-diabetic patients with moderate to
severe obstructive sleep apnea
Phase:
N/A
Details
Lead Sponsor:
St Vincent's University Hospital, Ireland
Collaborators:
Health Research Board, Ireland University College Dublin